Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 239

1.

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.

Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, Zhang Y, Cheng W, Zhao W.

Ann Surg Oncol. 2009 Feb;16(2):240-5. doi: 10.1245/s10434-008-0233-3. Epub 2008 Nov 26.

PMID:
19034577
[PubMed - indexed for MEDLINE]
2.

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.

Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M.

Virchows Arch. 2005 Jun;446(6):589-95. Epub 2005 May 19.

PMID:
15902486
[PubMed - indexed for MEDLINE]
3.

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.

Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ, Qu JM.

Ann Surg Oncol. 2010 Dec;17(12):3294-300. doi: 10.1245/s10434-010-1129-6. Epub 2010 Oct 15.

PMID:
20953721
[PubMed - indexed for MEDLINE]
4.

The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors.

Choi SY, Park H, Kang MK, Lee DK, Lee KD, Lee HS, Kim SW, Lee EN, Hong JC.

World J Surg Oncol. 2013 Nov 14;11:291. doi: 10.1186/1477-7819-11-291.

PMID:
24228637
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation.

Virk RK, Van Dyke AL, Finkelstein A, Prasad A, Gibson J, Hui P, Theoharis CG, Carling T, Roman SA, Sosa JA, Udelsman R, Prasad ML.

Mod Pathol. 2013 Jan;26(1):62-70. doi: 10.1038/modpathol.2012.152. Epub 2012 Aug 24.

PMID:
22918165
[PubMed - indexed for MEDLINE]
Free Article
6.

BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer.

Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, Park SY, Jung KC, Koo do H, Youn YK.

World J Surg. 2012 Feb;36(2):310-7. doi: 10.1007/s00268-011-1383-1.

PMID:
22190222
[PubMed - indexed for MEDLINE]
7.

Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.

Zheng X, Wei S, Han Y, Li Y, Yu Y, Yun X, Ren X, Gao M.

Ann Surg Oncol. 2013 Jul;20(7):2266-73. doi: 10.1245/s10434-012-2851-z. Epub 2013 Jan 31.

PMID:
23370668
[PubMed - indexed for MEDLINE]
8.

BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.

Kurtulmus N, Duren M, Ince U, Cengiz Yakicier M, Peker O, Aydın O, Altiok E, Giray S, Azizlerli H.

Endocrine. 2012 Oct;42(2):404-10. Epub 2012 Mar 17.

PMID:
22426956
[PubMed - indexed for MEDLINE]
9.

BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases.

Rodolico V, Cabibi D, Pizzolanti G, Richiusa P, Gebbia N, Martorana A, Russo A, Amato MC, Galluzzo A, Giordano C.

Cancer. 2007 Sep 15;110(6):1218-26.

PMID:
17685465
[PubMed - indexed for MEDLINE]
Free Article
10.

Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma.

Wang W, Zhao W, Wang H, Teng X, Wang H, Chen X, Li Z, Yu X, Fahey TJ 3rd, Teng L.

Ann Surg Oncol. 2012 Jan;19(1):31-6. doi: 10.1245/s10434-011-2096-2. Epub 2011 Oct 27.

PMID:
22033631
[PubMed - indexed for MEDLINE]
11.

BRAF(V600E) mutation and the biology of papillary thyroid cancer.

Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R.

Endocr Relat Cancer. 2008 Mar;15(1):191-205. doi: 10.1677/ERC-07-0212.

PMID:
18310287
[PubMed - indexed for MEDLINE]
Free Article
12.

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients.

Ito Y, Yoshida H, Maruo R, Morita S, Takano T, Hirokawa M, Yabuta T, Fukushima M, Inoue H, Tomoda C, Kihara M, Uruno T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A.

Endocr J. 2009;56(1):89-97. Epub 2008 Oct 8.

PMID:
18840924
[PubMed - indexed for MEDLINE]
Free Article
13.

The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas.

Kurt B, Yalçın S, Alagöz E, Karslıoğlu Y, Yigit N, Günal A, Deveci MS.

Endocr Pathol. 2012 Sep;23(3):135-40. doi: 10.1007/s12022-012-9218-7.

PMID:
22767446
[PubMed - indexed for MEDLINE]
14.

BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR.

Jeong D, Jeong Y, Park JH, Han SW, Kim SY, Kim YJ, Kim SJ, Hwangbo Y, Park S, Cho HD, Oh MH, Yang SH, Kim CJ.

Ann Surg Oncol. 2013 Mar;20(3):759-66. doi: 10.1245/s10434-012-2494-0. Epub 2012 Nov 21.

PMID:
23179992
[PubMed - indexed for MEDLINE]
15.

BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma.

Ahn D, Park JS, Sohn JH, Kim JH, Park SK, Seo AN, Park JY.

Auris Nasus Larynx. 2012 Apr;39(2):198-203. doi: 10.1016/j.anl.2011.07.011. Epub 2011 Aug 20.

PMID:
21862261
[PubMed - indexed for MEDLINE]
16.

The prevalence and prognostic value of BRAF mutation in thyroid cancer.

Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A.

Ann Surg. 2007 Sep;246(3):466-70; discussion 470-1.

PMID:
17717450
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas.

Nakayama H, Yoshida A, Nakamura Y, Hayashi H, Miyagi Y, Wada N, Rino Y, Masuda M, Imada T.

Anticancer Res. 2007 Sep-Oct;27(5B):3645-9.

PMID:
17972530
[PubMed - indexed for MEDLINE]
Free Article
18.

Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression.

Gandolfi G, Sancisi V, Torricelli F, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A.

J Clin Endocrinol Metab. 2013 May;98(5):E934-42. doi: 10.1210/jc.2012-3930. Epub 2013 Mar 26.

PMID:
23533235
[PubMed - indexed for MEDLINE]
19.

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park do J, Lee HS, Cho BY, Lee ES, Kim SW.

Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6.

PMID:
17054470
[PubMed - indexed for MEDLINE]
20.

Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.

Park SY, Park YJ, Lee YJ, Lee HS, Choi SH, Choe G, Jang HC, Park SH, Park do J, Cho BY.

Cancer. 2006 Oct 15;107(8):1831-8.

PMID:
16983703
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk